Previous 10 | Next 10 |
2024-06-05 08:21:51 ET Google’s parent company Alphabet ( NASDAQ: GOOG ) ( NASDAQ: GOOGL ) has tapped Anat Ashkenazi as its new chief financial officer.... Read the full article on Seeking Alpha For further details see: Alphabet taps Eli Lilly executiv...
2024-06-05 08:10:19 ET More on Eli Lilly Eli Lilly and Company (LLY) Lilly Oncology ASCO Investor Event (Transcript) Eli Lilly's Growth And Challenges: A Cautious Buy Eli Lilly: Addressing Supply Challenges Should Accelerate Growth Eli Lilly CFO Anat Ashkenaz...
2024-06-05 08:00:24 ET More on Eli Lilly Eli Lilly's Growth And Challenges: A Cautious Buy Eli Lilly: Addressing Supply Challenges Should Accelerate Growth Eli Lilly wins favorable terms for obesity drug use in U.K. Eli Lilly sees improving availability of GL...
Lilly announces departure of Anat Ashkenazi, chief financial officer PR Newswire INDIANAPOLIS , June 5, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Anat Ashkenazi has resigned as chief financial officer to pursue a career opportuni...
2024-06-04 16:02:02 ET More on Markets Goldman Sachs: Core inflation will cool to 2.2% in developed economies Going Into June, SPY Or VXF, Which Is The Better Buy? (Technical Analysis) The Reversal Of The Reversal S&P 500 Investor Focus Shif...
2024-06-04 15:40:11 ET More on Viking Therapeutics What Makes Viking Therapeutics An Attractive Takeover Target Or Big Pharma Partner Viking Therapeutics: The Metabolic Masterpiece Primed To Be Acquired Viking Therapeutics, Inc. (VKTX) Q1 2024 Earnings Call Transcrip...
2024-06-04 14:57:26 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly and Company (LLY) Lilly Oncology ASCO Investor Event (Transcript) Eli Lilly's Growth And Challenges: A Cautious Buy Novo Nordisk: The Market Is Right, Don't Fight Against It Eli Lilly sees...
2024-06-04 13:50:00 ET Summary More than 800 million people are estimated to be overweight or obese worldwide, and the growing prevalence of obesity, despite the availability of various treatments, suggests that isn’t going to change. The potential $500 billion market for G...
2024-06-04 13:33:07 ET Eli Lilly and Company (LLY) Lilly Oncology ASCO Investor Event June 2, 2024 08:30 PM ET Company Participants Jake Van Naarden - Executive VP & President of Loxo Lillian Smyth - Senior Vice President and Global Development Head for Breast Ca...
2024-06-04 10:37:18 ET More on Eli Lilly Eli Lilly's Growth And Challenges: A Cautious Buy Eli Lilly: Addressing Supply Challenges Should Accelerate Growth Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly granted exclusive license to Qu...
News, Short Squeeze, Breakout and More Instantly...
2024-07-29 09:20:00 ET While the market for anti-obesity medicines is characterized today by a fight between Novo Nordisk 's (NYSE: NVO) drug Wegovy and Eli Lilly 's (NYSE: LLY) drug Zepbound, that won't always be the case. Over the coming years, the competitive dynamics of ...
2024-07-29 07:30:00 ET When a major player announces good news in a lucrative market like weight loss drugs, it's often enough to drive shares of competitors down based on the assumption that they will have struggles ahead. That's just what happened after an announcement by Roche Hold...
2024-07-27 07:15:00 ET According to some research, bull markets tend to last an average of 2.6 years. The one we are currently experiencing has been going on for almost two years -- maybe it will soon end, maybe it won't. Equities that can perform well throughout bull runs might be good to ...